Natural Killer (NK) Cell Therapeutics Market Report

Global and China Natural Killer (NK) Cell Therapeutics Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 16, 2022
  • PAGES：168
  • REPORT CODE：GMM1378773
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Natural Killer (NK) Cell Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Takeda Pharmaceutical (Japan)

    • NantKwest Inc (USA)

    • Chipscreen Biosciences (China)

    • Affimed NV (Netherlands)

    • Innate Pharma SA (France)

    • Altor BioScience Corporation (USA)

    • Bristol-Myers Squibb (USA)

    • Sorrento Therapeutics Inc (USA)

    • NKT Therapeutics (USA)

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Mogamulizumab

    • Lorvotuzumab Mertansine

    • Others

    Application:

    • Cancer

    • Cardiovascular Diseases

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Natural Killer (NK) Cell Therapeutics Industry Overview

      • 1.1.1 Natural Killer (NK) Cell Therapeutics Market Scope and Market Segments

      • 1.1.2 Natural Killer (NK) Cell Therapeutics Industry Characteristics

      • 1.1.3 Global and China Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Natural Killer (NK) Cell Therapeutics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Mogamulizumab

      • 1.2.2 Lorvotuzumab Mertansine

      • 1.2.3 Others

    • 1.3 Global Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Cancer

      • 1.3.2 Cardiovascular Diseases

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Natural Killer (NK) Cell Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Natural Killer (NK) Cell Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Natural Killer (NK) Cell Therapeutics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Natural Killer (NK) Cell Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Natural Killer (NK) Cell Therapeutics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Natural Killer (NK) Cell Therapeutics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Natural Killer (NK) Cell Therapeutics Industry PEST Analysis

    • 2.3 Natural Killer (NK) Cell Therapeutics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Natural Killer (NK) Cell Therapeutics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Natural Killer (NK) Cell Therapeutics Industry

    Chapter 3 Global and China Natural Killer (NK) Cell Therapeutics Market, by Manufacturer

    • 3.1 Global and China Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Natural Killer (NK) Cell Therapeutics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Natural Killer (NK) Cell Therapeutics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Natural Killer (NK) Cell Therapeutics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Natural Killer (NK) Cell Therapeutics Market Top 3 Players

    Chapter 4 Global and China Natural Killer (NK) Cell Therapeutics Market, by Type (2017-2028)

    • 4.1 Natural Killer (NK) Cell Therapeutics Market Trend, by Type

    • 4.2 Global Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Natural Killer (NK) Cell Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Natural Killer (NK) Cell Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Natural Killer (NK) Cell Therapeutics Price Trend, by Type (2017-2028)

    • 4.3 China Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Natural Killer (NK) Cell Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Natural Killer (NK) Cell Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Natural Killer (NK) Cell Therapeutics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Natural Killer (NK) Cell Therapeutics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Natural Killer (NK) Cell Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Natural Killer (NK) Cell Therapeutics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Natural Killer (NK) Cell Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Natural Killer (NK) Cell Therapeutics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Natural Killer (NK) Cell Therapeutics Market Analysis

    • 7.1 North America Natural Killer (NK) Cell Therapeutics Market, by Type

    • 7.2 North America Natural Killer (NK) Cell Therapeutics Market, by Application

    • 7.3 North America Natural Killer (NK) Cell Therapeutics Market Analysis and Forecast, by Country

      • 7.3.1 United States Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Natural Killer (NK) Cell Therapeutics Market Analysis

    • 8.1 Europe Natural Killer (NK) Cell Therapeutics Market, by Type

    • 8.2 Europe Natural Killer (NK) Cell Therapeutics Market, by Application

    • 8.3 Europe Natural Killer (NK) Cell Therapeutics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Natural Killer (NK) Cell Therapeutics Market Analysis

    • 9.1 APAC Natural Killer (NK) Cell Therapeutics Market, by Type

    • 9.2 APAC Natural Killer (NK) Cell Therapeutics Market, by Application

    • 9.3 APAC Natural Killer (NK) Cell Therapeutics Market Analysis and Forecast, by Country

      • 9.3.1 China Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Analysis

    • 10.1 Latin America, Middle East and Africa Natural Killer (NK) Cell Therapeutics Market, by Type

    • 10.2 Latin America, Middle East and Africa Natural Killer (NK) Cell Therapeutics Market, by Application

    • 10.3 Latin America, Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Natural Killer (NK) Cell Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Natural Killer (NK) Cell Therapeutics Company Profiles

      • 11.1 Takeda Pharmaceutical (Japan)

        • 11.1.1 Takeda Pharmaceutical (Japan) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Product Profiles, Application and Specification

        • 11.1.3 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 NantKwest Inc (USA)

        • 11.2.1 NantKwest Inc (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 NantKwest Inc (USA) Natural Killer (NK) Cell Therapeutics Product Profiles, Application and Specification

        • 11.2.3 NantKwest Inc (USA) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Chipscreen Biosciences (China)

        • 11.3.1 Chipscreen Biosciences (China) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Product Profiles, Application and Specification

        • 11.3.3 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Affimed NV (Netherlands)

        • 11.4.1 Affimed NV (Netherlands) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Product Profiles, Application and Specification

        • 11.4.3 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Innate Pharma SA (France)

        • 11.5.1 Innate Pharma SA (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Product Profiles, Application and Specification

        • 11.5.3 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Altor BioScience Corporation (USA)

        • 11.6.1 Altor BioScience Corporation (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Product Profiles, Application and Specification

        • 11.6.3 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Bristol-Myers Squibb (USA)

        • 11.7.1 Bristol-Myers Squibb (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Product Profiles, Application and Specification

        • 11.7.3 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Sorrento Therapeutics Inc (USA)

        • 11.8.1 Sorrento Therapeutics Inc (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Sorrento Therapeutics Inc (USA) Natural Killer (NK) Cell Therapeutics Product Profiles, Application and Specification

        • 11.8.3 Sorrento Therapeutics Inc (USA) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 NKT Therapeutics (USA)

        • 11.9.1 NKT Therapeutics (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Product Profiles, Application and Specification

        • 11.9.3 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Natural Killer (NK) Cell Therapeutics Industry Investment Prospect and Risk Assessment

    • 12.1 Natural Killer (NK) Cell Therapeutics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Natural Killer (NK) Cell Therapeutics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Natural Killer (NK) Cell Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure China Natural Killer (NK) Cell Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure Global Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Mogamulizumab (2017-2028)

    • Figure Global Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Lorvotuzumab Mertansine (2017-2028)

    • Figure Global Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Cancer (2017-2028)

    • Figure Global Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Cardiovascular Diseases (2017-2028)

    • Figure Global Natural Killer (NK) Cell Therapeutics Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Natural Killer (NK) Cell Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Natural Killer (NK) Cell Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Natural Killer (NK) Cell Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Natural Killer (NK) Cell Therapeutics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Natural Killer (NK) Cell Therapeutics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Natural Killer (NK) Cell Therapeutics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Natural Killer (NK) Cell Therapeutics Market Share, by Manufacturer in 2021

    • Figure Global and China Natural Killer (NK) Cell Therapeutics Market Share, by Manufacturer in 2022

    • Table Global Natural Killer (NK) Cell Therapeutics Sales Volume, by Type (2017-2028)

    • Table Global Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Global Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Global Natural Killer (NK) Cell Therapeutics Sales Value, by Type (2017-2028)

    • Table Global Natural Killer (NK) Cell Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure Global Natural Killer (NK) Cell Therapeutics Price Trend, by Type (2017-2028)

    • Table China Natural Killer (NK) Cell Therapeutics Sales Volume, by Type (2017-2028)

    • Table China Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure China Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table China Natural Killer (NK) Cell Therapeutics Sales Value, by Type (2017-2028)

    • Table China Natural Killer (NK) Cell Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure China Natural Killer (NK) Cell Therapeutics Price Trend, by Type (2017-2028)

    • Table Global Natural Killer (NK) Cell Therapeutics Sales Volume, by Application (2017-2028)

    • Table Global Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Global Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table Global Natural Killer (NK) Cell Therapeutics Sales Value, by Application (2017-2028)

    • Table Global Natural Killer (NK) Cell Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure Global Natural Killer (NK) Cell Therapeutics Sales Value Share, by Application (2017-2028)

    • Table China Natural Killer (NK) Cell Therapeutics Sales Volume, by Application (2017-2028)

    • Table China Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table China Natural Killer (NK) Cell Therapeutics Sales Value, by Application (2017-2028)

    • Table China Natural Killer (NK) Cell Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Natural Killer (NK) Cell Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Natural Killer (NK) Cell Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Table North America Natural Killer (NK) Cell Therapeutics Sales Volume, by Type (2017-2028)

    • Table North America Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure North America Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table North America Natural Killer (NK) Cell Therapeutics Sales Volume, by Application (2017-2028)

    • Table North America Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure North America Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure United States Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Europe Natural Killer (NK) Cell Therapeutics Sales Volume, by Type (2017-2028)

    • Table Europe Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Europe Natural Killer (NK) Cell Therapeutics Sales Volume, by Application (2017-2028)

    • Table Europe Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure UK Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure France Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure France Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table APAC Natural Killer (NK) Cell Therapeutics Sales Volume, by Type (2017-2028)

    • Table APAC Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table APAC Natural Killer (NK) Cell Therapeutics Sales Volume, by Application (2017-2028)

    • Table APAC Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure India Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure India Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Natural Killer (NK) Cell Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Natural Killer (NK) Cell Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Takeda Pharmaceutical (Japan) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takeda Pharmaceutical (Japan) Product Profiles, Application and Specification

    • Table Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table NantKwest Inc (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table NantKwest Inc (USA) Product Profiles, Application and Specification

    • Table NantKwest Inc (USA) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Chipscreen Biosciences (China) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Chipscreen Biosciences (China) Product Profiles, Application and Specification

    • Table Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Affimed NV (Netherlands) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Affimed NV (Netherlands) Product Profiles, Application and Specification

    • Table Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Innate Pharma SA (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Innate Pharma SA (France) Product Profiles, Application and Specification

    • Table Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Altor BioScience Corporation (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Altor BioScience Corporation (USA) Product Profiles, Application and Specification

    • Table Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol-Myers Squibb (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb (USA) Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sorrento Therapeutics Inc (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sorrento Therapeutics Inc (USA) Product Profiles, Application and Specification

    • Table Sorrento Therapeutics Inc (USA) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table NKT Therapeutics (USA) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table NKT Therapeutics (USA) Product Profiles, Application and Specification

    • Table NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US